Medicines (Designated Prescriber: Pharmacists) Regulations

Regulatory impact statement

Publication Date: 
21 May 2014

This regulatory impact statement considers whether allowing Pharmacist Prescribers prescribing rights will enable suitably qualified pharmacists more practice flexibility and improve access to integrated health services for consumers. The proposal for regulation of this group is consistent with the Government’s commitment to utilise health practitioners to their full capability.

Regulatory impact statements

Back to top